Organization Overview
Alternative names
allopurinol (zyloprim) (2 trials)
bacille calmette-guerin (1 trial)
bupivacaine (Exparel) (3 trials)
clindamycin (cleocin) (1 trial)
clonidine (catapres) (1 trial)
eculizumab (Soliris) (2 trials)
epinephrine (levophed) (2 trials)
esmolol (brevibloc) (3 trials)
ethinyl estradiol (Estinyl) (1 trial)
gabapentin (neurontin) (1 trial)
gestodene (Femodene) (1 trial)
hydrochlorothiazide (esidrix) (1 trial)
labetalol (trandate) (2 trials)
alteplase (Activase) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (3 trials)
autologous dendritic cells (2 trials)
bone marrow derived mesenchymal stem cells (2 trials)
cisplatin (platinol) (4 trials)
evolocumab (repatha) (1 trial)
fish oil (Omegavan) (4 trials)
icosapent ethyl (vascepa) (3 trials)
immune globulin (human) (Gamastan) (4 trials)
abiraterone (zytiga) (1 trial)
acetaminophen (tylenol) (2 trials)
acetylcysteine (mucomyst) (1 trial)
aminosalicylic acid (Paser) (1 trial)
apalutamide (erleada) (1 trial)
atorvastatin (lipitor) (1 trial)
autologous cd34+ cells (1 trial)
autologous hematopoietic stem cells (1 trial)
autologous mesenchymal stem cells (1 trial)
bevacizumab (avastin) (3 trials)
bortezomib (velcade) (2 trials)
C1 Esterase Inhibitor (Human) (Cinryze) (3 trials)
cabozantinib (cometriq) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
dexmedetomidine (precedex) (1 trial)
diphenhydramine (benadryl) (1 trial)
durvalumab (imfinzi) (2 trials)
enzalutamide (xtandi) (1 trial)
estradiol (progynon depot) (1 trial)
everolimus (zortress) (2 trials)
Filgrastim (neupogen) (1 trial)
fludarabine (fludara) (2 trials)
gemcitabine (gemzar) (3 trials)
lymphocyte immune globulin, anti-thymocyte globulin (equine) (Atgam) (1 trial)
methylprednisolone (medrol) (1 trial)
nitric oxide (inomax) (1 trial)
pancrelipase (creon) (1 trial)
paricalcitol (zemplar) (1 trial)
pasireotide (signifor) (2 trials)
pembrolizumab (keytruda) (8 trials)
pertuzumab (perjeta) (1 trial)
pravastatin (pravachol) (1 trial)
allogeneic adipose derived mesenchymal stem cell (1 trial)
allogeneic cardiosphere-derived cells (2 trials)
allogeneic human csps (1 trial)
alprostadil (prostin) (1 trial)
blinatumomab (blincyto) (1 trial)
calcitriol (rocaltrol) (1 trial)
cd56-enriched donor lymphocyte (1 trial)
escitalopram (lexapro) (1 trial)
fludeoxyglucose f-18 (1 trial)
fulvestrant (faslodex) (1 trial)
lubiprostone (amitiza) (1 trial)
multi-valent pneumococcal conjugate vaccine (1 trial)
Abnormalities, Drug-Induced (Phase 4)
Acromegaly (Phase 3)
ACTH-Secreting Pituitary Adenoma (Phase 2)
ACTH Syndrome, Ectopic (Phase 2)
Acute Coronary Syndrome (Phase 2)
Adenocarcinoma (Phase 2)
Adenoma (Phase 2)
Amenorrhea (Phase 2)
Amyotrophic Lateral Sclerosis (Phase 3)
Angina Pectoris (Phase 4)
Angioedemas, Hereditary (Phase 2)
Anxiety Disorders (Phase 3)
Asthenozoospermia (Phase 3)
Astrocytoma (Phase 2)
Atherosclerosis (Phase 2)
Bipolar Disorder (Phase 4)
Blood Loss, Surgical (Phase 4)
Brain Injuries (Phase 2)
Brain Injuries, Traumatic (Phase 2)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Cachexia (Phase 2)
Calcinosis (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Cardiac Complexes, Premature (Phase 2)
Cardiomyopathies (Phase 1)
Cardiomyopathy, Dilated (Phase 1)
Cardiotoxicity (Phase 2)
Cardiovascular Diseases (Phase 4)
Central Nervous System Diseases (Phase 2)
Cerebral Infarction (Phase 2)
Chest Pain (Phase 2)
Constipation (Phase 4)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Coronavirus Infections (Phase 4)
Cough (Phase 4)
Crohn Disease (Phase 4)
Cushing Syndrome (Phase 2)
Dehydration (Phase 3)
Delayed Graft Function (Phase 2)
Depression (Phase 3)
Depressive Disorder (Phase 3)
Depressive Disorder, Major (Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diarrhea (Phase 2)
Digestive System Diseases (Phase 4)
Disease (Phase 4)
Embolism (Phase 4)
Endometrial Neoplasms (Phase 1)
Endometritis (Phase 4)
Exocrine Pancreatic Insufficiency (Phase 2)
Eye Diseases (Phase 3)
Familial Primary Pulmonary Hypertension (Phase 1)
Femoracetabular Impingement (Phase 4)
Gastrointestinal Diseases (Phase 4)
Gastrointestinal Neoplasms (Phase 4)
Genital Diseases, Male (Phase 2)
Genital Neoplasms, Male (Phase 2)
Glioblastoma (Phase 3)
Glioma (Phase 2)
Graves Ophthalmopathy (Phase 3)
Head and Neck Neoplasms (Phase 2)
Heart Diseases (Phase 4)
Heart Failure (Phase 2)
Heart Failure, Diastolic (Phase 2)
Hemolysis (Phase 4)
Hemorrhage (Phase 4)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis C (Phase 2)
Hepatitis C, Chronic (Phase 2)
Hepatitis, Chronic (Phase 2)
HIV Infections (Phase 3)
Hodgkin Disease (Phase 1)
Hypercholesterolemia (Phase 4)
Hyperlipidemias (Phase 4)
Hypersensitivity (Phase 2)
Hypertension (Phase 4)
Hypoglycemia (Phase 1)
Hypoxia (Phase 2)
Infarction (Phase 4)
Inflammation (Phase 2)
Inflammatory Bowel Diseases (Phase 4)
Intestinal Diseases (Phase 4)
Irritable Bowel Syndrome (Phase 2)
Ischemia (Phase 2)
Kidney Diseases (Phase 3)
Kidney Failure, Chronic (Phase 4)
Kidney Neoplasms (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Lymphoid (Phase 1)
Liver Cirrhosis (Phase 2)
Liver Neoplasms (Phase 2)
Long QT Syndrome (Phase 4)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Meningioma (Phase 2)
Mental Disorders (Phase 2)
Motor Neuron Disease (Phase 3)
Mucocutaneous Lymph Node Syndrome (Phase 2)
Multiple Myeloma (Phase 1)
Multiple Sclerosis (Phase 4)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Muscular Dystrophies (Phase 4)
Muscular Dystrophy, Duchenne (Phase 4)
Myelodysplastic Syndromes (Phase 2)
Myocardial Infarction (Phase 2)
Myocardial Ischemia (Phase 4)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms by Site (Phase 2)
Neoplasms, Glandular and Epithelial (Phase 2)
Neoplasms, Plasma Cell (Phase 1)
Neoplasms, Second Primary (Phase 1)
Neuralgia (Phase 4)
Oligodendroglioma (Phase 2)
Oligospermia (Phase 3)
Oropharyngeal Neoplasms (Phase 2)
Osteosarcoma (Phase 1)
Ovarian Neoplasms (Phase 2)
Pain, Postoperative (Phase 4)
Pancreatic Neoplasms (Phase 1)
Parkinson Disease (Phase 2)
Parkinson Disease, Secondary (Phase 2)
Pituitary ACTH Hypersecretion (Phase 2)
Pituitary Diseases (Phase 2)
Pituitary Neoplasms (Phase 2)
Postpartum Hemorrhage (Phase 4)
Pouchitis (Phase 2)
Prehypertension (Phase 2)
Preleukemia (Phase 2)
Prolactinoma (Phase 2)
Prostatic Diseases (Phase 2)
Prostatic Neoplasms (Phase 3)
Pulmonary Embolism (Phase 4)
Pulmonary Heart Disease (Phase 4)
Pulmonary Infarction (Phase 4)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 2)
REM Sleep Behavior Disorder (Phase 2)
Renal Insufficiency (Phase 2)
Reperfusion Injury (Phase 2)
Respiratory Aspiration (Phase 1)
Respiratory Insufficiency (Phase 1)
Retinitis (Phase 1)
Retinitis Pigmentosa (Phase 1)
Sarcoma (Phase 1)
Sclerosis (Phase 4)
Severe Acute Respiratory Syndrome (Phase 4)
Sexual Dysfunction, Physiological (Phase 1)
Sexual Dysfunctions, Psychological (Phase 1)
Small Cell Lung Carcinoma (Phase 3)
Stroke (Phase 3)
Syndrome (Phase 2)
Teratozoospermia (Phase 3)
Thromboembolism (Phase 3)
Thyroid Diseases (Phase 3)
Triple Negative Breast Neoplasms (Phase 2)
Urogenital Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Vascular Diseases (Phase 3)
Venous Thromboembolism (Phase 3)
Ventricular Dysfunction (Phase 4)
Ventricular Dysfunction, Left (Phase 4)
Ventricular Dysfunction, Right (Phase 4)
Vitamin D Deficiency (Phase 4)
Vomiting (Phase 4)
Wasting Syndrome (Phase 1)
Weight Loss (Phase 2)
Wounds and Injuries (Phase 2)